| Impaired mitophagy and protein acetylation levels in fibroblasts from Parkinson’s disease patients SMS Yakhine-Diop, M Niso-Santano, M Rodríguez-Arribas, ... Molecular neurobiology 56, 2466-2481, 2019 | 63 | 2019 |
| An overview of FGF-23 as a novel candidate biomarker of cardiovascular risk S Vázquez-Sánchez, J Poveda, JA Navarro-García, L González-Lafuente, ... Frontiers in Physiology 12, 632260, 2021 | 54 | 2021 |
| PTH, vitamin D, and the FGF‐23–klotho axis and heart: going beyond the confines of nephrology JA Navarro‐García, M Fernández‐Velasco, C Delgado, JF Delgado, ... European Journal of Clinical Investigation 48 (4), e12902, 2018 | 53 | 2018 |
| Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes JA Navarro-García, C Delgado, M Fernández-Velasco, A Val-Blasco, ... Nephrology Dialysis Transplantation 34 (11), 1864-1875, 2019 | 52 | 2019 |
| Enhanced Klotho availability protects against cardiac dysfunction induced by uraemic cardiomyopathy by regulating Ca2+ handling JA Navarro‐García, A Rueda, T Romero‐García, J Aceves‐Ripoll, ... British Journal of Pharmacology 177 (20), 4701-4719, 2020 | 25 | 2020 |
| Intracellular calcium mishandling leads to cardiac dysfunction and ventricular arrhythmias in a mouse model of propionic acidemia M Tamayo, A Fulgencio-Covián, JA Navarro-García, A Val-Blasco, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (1), 165586, 2020 | 22 | 2020 |
| Klotho relieves inflammation and exerts a cardioprotective effect during renal ischemia/reperfusion-induced cardiorenal syndrome CVC Junho, L Gonzalez-Lafuente, RS Neres-Santos, JA Navarro-García, ... Biomedicine & Pharmacotherapy 153, 113515, 2022 | 21 | 2022 |
| Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease C Yanucil, D Kentrup, I Campos, B Czaya, K Heitman, D Westbrook, ... Kidney international 102 (2), 261-279, 2022 | 21 | 2022 |
| Resistant hypertension: new insights and therapeutic perspectives LM Ruilope, E Rodríguez-Sánchez, JA Navarro-García, J Segura, A Órtiz, ... European Heart Journal-Cardiovascular Pharmacotherapy 6 (3), 188-193, 2020 | 19 | 2020 |
| Oxidative status before and after renal replacement therapy: differences between conventional high flux hemodialysis and on-line hemodiafiltration JA Navarro-García, E Rodríguez-Sánchez, J Aceves-Ripoll, ... Nutrients 11 (11), 2809, 2019 | 19 | 2019 |
| Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients E Rodríguez-Sánchez, JA Navarro-García, J Aceves-Ripoll, ... Nefrología (English Edition) 39 (2), 184-191, 2019 | 15 | 2019 |
| Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9–Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA … H Pulido-Olmo, E Rodríguez-Sánchez, JA Navarro-García, MG Barderas, ... Frontiers in Immunology 8, 853, 2017 | 15 | 2017 |
| Unilateral acute renal ischemia-reperfusion injury induces cardiac dysfunction through intracellular calcium mishandling CVC Junho, L González-Lafuente, JA Navarro-García, ... International Journal of Molecular Sciences 23 (4), 2266, 2022 | 11 | 2022 |
| Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure M Tamayo, L Martín‐Nunes, A Val‐Blasco, MJ GM‐Piedras, ... British Journal of Pharmacology 177 (14), 3273-3290, 2020 | 11 | 2020 |
| Lifetime cardiovascular risk is associated with a multimarker score of systemic oxidative status in young adults independently of traditional risk factors E RodrÍguez-SÁnchez, JA Navarro-GarcÍa, J Aceves-Ripoll, ... Translational Research 212, 54-66, 2019 | 11 | 2019 |
| Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure A Val-Blasco, JA Navarro-García, M Tamayo, MJ Piedras, P Prieto, ... Frontiers in Physiology 9, 702, 2018 | 9 | 2018 |
| Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets JA Navarro-García, L González-Lafuente, M Fernández-Velasco, ... Frontiers in Physiology 12, 775029, 2021 | 8 | 2021 |
| Oxidized Low-Density Lipoprotein Associates with Ventricular Stress in Young Adults and Triggers Intracellular Ca2+ Alterations in Adult Ventricular Cardiomyocytes E Rodríguez-Sánchez, JA Navarro-García, L González-Lafuente, ... Antioxidants 9 (12), 1213, 2020 | 8 | 2020 |
| The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23 JA Navarro-García, R Salguero-Bodes, L González-Lafuente, ... BMC medicine 20 (1), 14, 2022 | 7 | 2022 |
| Analysis of global oxidative status using multimarker scores reveals a specific association between renal dysfunction and diuretic therapy in older adults E Rodríguez-Sánchez, JA Navarro-García, J Aceves-Ripoll, ... The Journals of Gerontology: Series A 76 (7), 1198-1205, 2021 | 6 | 2021 |
Elena Rodriguez-SanchezDavid Geffen School of Medicine at UCLAVerified email at mednet.ucla.edu
